Similarly, in another study in patients with newly diagnosed FLT3-ITD-mutated AML, a high allelic ratio (≥0.51) and a FLT3-ITD insertion site in TKD1 predicted low complete remission (CR) rates and poor survival [39]. This evidence concerns the gene FLT3 and acute myeloid leukemia.